What is the most important question to ask in early phase clinical drug development?
-
Chair(s):
Dr. Geert Jan Groeneveld,
CSO/CMO,Centre for Human Drug Research, Leiden, The NetherlandsProf. Adam Cohen CSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands
-
Session description:
Question based drug development
Professor Adam Cohen1 1 CSO/CMO, Centre for Human Drug Research, Leiden, The NetherlandsDe-risking FIH studies
Dr Jules Heuberger
Senior Clinical Scientist, Centre for Human Drug Research, Leiden, The NetherlandsProof-of-pharmacology in early phase clinical drug studies
Dr Geert Jan Groeneveld
CSO/CMO,Centre for Human Drug Research, Leiden, The NetherlandsAccelerated proof-of-concept in early clinical development
Dr Robert Rissmann
Research Director, Centre for Human Drug Research, Leiden, The NetherlandsAnalysis of wearables generated data as pharmacological biomarkers using AI
Ahnjili Zhuparris
Product manager trial@home,Centre for Human Drug Research, Leiden, The Netherlands -
Sponsored by:
Speakers
-
Ahnjili Zhuparris Product manager trial@home,Centre for Human Drug Research, Leiden, The NetherlandsAhnjili ZhuparrisProduct manager trial@home,Centre for Human Drug Research, Leiden, The Netherlands
-
Dr Geert Jan GroeneveldCSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands
-
Dr Jules Heuberger Senior Clinical Scientist,Centre for Human Drug Research, Leiden, The NetherlandsDr Jules HeubergerSenior Clinical Scientist,Centre for Human Drug Research, Leiden, The Netherlands
-
Dr Robert RissmannResearch Director,Centre for Human Drug Research, Leiden, The Netherlands
-
Professor Adam CohenCSO/CMO,Centre for Human Drug Research, Leiden, The Netherlands
Leave A Comment